Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-α, interleukin 6, and interferon-γ production by peripheral blood mononuclear cells

Journal of Rheumatology

Volumn 24, Issue 1, 1997, Pages 55-60

  Van Den Borne, Ben E E M ^a   Dijkmans, Ben A C ^a   De Rooij, Henny H ^a   Le Cessie, Saskia ^a   Verweij, Cornelis L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

chloroquine; cytokines; hydroxychloroquine; rheumatoid arthritis

Indexed keywords

CHLOROQUINE; GAMMA INTERFERON; HYDROXYCHLOROQUINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; MONOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CHLOROQUINE; HUMANS; HYDROXYCHLOROQUINE; INTERFERON TYPE II; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; PHYTOHEMAGGLUTININS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031038229     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mackenzie AH: Antimalarial drugs for rheumatoid arthritis. Am J Med 1983;75:48-58.
2. Wollheim FA, Hanson A, Laurell CB: Chloroquine treatment in rheumatoid arthritis. Correlation of clinical response to plasma protein changes and chloroquine levels. Scand J Rheumatol 1978;7:171-6.
3. Bjelle A, Bjornham A, Larson A, Mjorndal T: Chloroquine in long-term treatment of rheumatoid arthritis. Clin Rheumatol 1983;2:393-9.
4. Clark P, Casas E, Tugwell P, et al: Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial. Ann Intern Med 1993;119:1067-71.
5. Esdaile JM, Suissa S, Shiroky JB, et al: A randomized trial of hydroxychloroquine in early rheumatoid arthritis: The HERA study. Am J Med 1995;98:156-68.
6. Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum 1990;33:1449-61.
7. Salmeron G, Lipsky PE: Immunosuppressive potential of antimalarials. Am J Med 1983;75:19-24.
8. Picot S, Peyron F, Vuillez JP, Polack B, Ambroise-Thomas P: Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro (letter). J Infect Dis 1991;164:830.
9. Landewe RB, Miltenburg AM, Breedveld FC, Daha MR, Dijkmans BA: Cyclosporine and chloroquine synergistically inhibit the interferon-gamma production by CD4 positive and CD8 positive synovial T cell clones derived from a patient with rheumatoid arthritis. J Rheumatol 1992;19:1353-7.
10. Sperber K, Quraishi H, Kalb TH, Panja A, Stecher V, Mayer L: Selective regulation of cytokine secretion by hydroxychloroquine: Inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells. J Rheumatol 1993;20:803-8.
11. Engelberts I, Möller A, Schoen GJ, Van der Linden CJ, Buurman WA: Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res 1991;10:133-40.
12. Helle M, Boeije L, de Groot E, de Vos A, Aarden L: Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: Synovial fluids and sera. J Immunol Methods 1991;138:47-56.
13. Miltenburg AM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC: T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 1992;35:603-10.
14. Picot S, Peyron F, Donadille A, Vuillez JP, Barbe G, Ambroise-Thomas P: Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism. Immunology 1993;80:127-33.
15. Zhu X, Ertel W, Ayala A, Morrison MH, Perrin MM, Chaudry IH: Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription. Immunology 1993;80:122-6.
16. Sigal NH, Dumont FJ: Cyclosporin A, FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 1992;10:519-60.
17. Kloppenburg M, Brinkman BMN, de Rooij-Dijk HH, et al: The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes. Antimicrob Agents Chemother 1996;40:934-40.
18. French JK, Hurst NP, O'Donnell ML, Betts WH: Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: Relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis 1987;46:42-5.
19. Hurst NP, French JK, Bell AL, et al: Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phopsholipid methylation and arachidonic acid release by human blood monocytes. Biochem Pharmacol 1986;35:3083-9.
20. Tett SE, Cutler DJ, Day RO, Brown KF: A dose-ranging study of the pharmacokinetics of hydroxychloroquine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 1988;26:303-13.
21. Panayi GS: The pathogenesis of rheumatoid arthritis: From molecules to the whole patient. Br J Rheumatol 1993;32:533-6.